Kevin Herde
2016 - Sorrento Therapeutics
In 2016, Kevin Herde earned a total compensation of $791.7K as Former EVP and Chief Financial Officer at Sorrento Therapeutics.
Compensation breakdown
| Option Awards | $557,700 |
|---|---|
| Salary | $233,977 |
| Total | $791,677 |
Herde received $557.7K in option awards, accounting for 70% of the total pay in 2016.
Herde also received $234K in salary.
Rankings
In 2016, Kevin Herde's compensation ranked 9,324th out of 14,075 executives tracked by ExecPay. In other words, Herde earned more than 33.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,324 out of 14,075 | 34th |
Division Manufacturing | 3,602 out of 5,489 | 34th |
Major group Chemicals And Allied Products | 1,245 out of 1,895 | 34th |
Industry group Drugs | 987 out of 1,538 | 36th |
Industry Biological Products, Except Diagnostic Substances | 169 out of 279 | 39th |
Source: SEC filing on June 26, 2017.
Herde's colleagues
We found five more compensation records of executives who worked with Kevin Herde at Sorrento Therapeutics in 2016.
2016
Henry Ji
Sorrento Therapeutics
Chief Executive Officer
2016
George Ng
Sorrento Therapeutics
Chief Administrative Officer
2016
Jeffrey Su
Sorrento Therapeutics
Chief Operating Officer
2016
Jerome Zeldis
Sorrento Therapeutics
Chief Medical Officer
2016
Douglas Langston
Sorrento Therapeutics